Page 226 - ASHG 2013 Program Guide

POSTER SESSIONS
  213
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
2463
W The Industry Pharmacogenomics Working
Group perspective on providing individual research
results and incidental findings to clinical tria
research participants.
S. K. Prucka, L. J. Arnold,
J. E. Brandt, S. Gilardi, L. C. Harty, F. Hong, J. S.
Malia, D. J. Pulford.
2464
T Interest in different types of individual genome
sequencing results among younger breast cancer
patients.
M. R. Ray, J. Ivanovich, B. B. Biesecker, L. G.
Dressler, R. Dresser, M. S. Goodman, P. J. Goodfellow, K.
A. Kaphingst.
2465
W Ethically optimized consents for pediatric
whole genome sequencing.
R. Zlotnik Shaul, M. S.
Meyn, M. Szego, R. Hayeems, C. Shuman, N. Monfared,
S. Bowdin.
2466
T Evaluation of ACMG recommended incidental
findings in clinical whole exome sequencing
E.
Haverfield, A. Daly, A. Fuller, N. Smaoui, K. Retterer, P.
Vitazka, G. Richard, W. Chung, S. Bale.
2467
W Giving and receiving: Comparing parents’,
paediatricians’ and genetic health professionals’
opinions about uncertain chromosomal microarray
results.
E. Turbitt, D. Amor, J. Halliday, S. Metcalfe.
2468
T Development of a decision aid for the selection
of incidental genome sequencing results.
Y. Bombard,
K. Schrader, E. Glogowski, M. Salerno, S. Patil, M. Massie,
R. Rau-Murthy, M. Corines, C. Manschreck, J. Vijai, Z.
Stadler, S. Lipkin, K. Offit, M. Robson, (first and second
authors have equal contributions).
2469
W Actionable incidental findings in the 1000
Genomes dataset.
E. Olfson, C. E. Cottrell, N. O.
Davidson, N. O. Stitziel, L. Chen, S. Hartz, S. Koul, R.
Nagarajan, N. L. Saccone, L. J. Bierut.
2470
T Binning framework for a decision aid for
the selection of incidental genome sequencing
results.
K. Schrader, Y. Bombard, E. Glogowski, M.
Salerno, S. Patil, M. Massie, R. Rau-Murthy, M. Corines,
C. Manschreck, J. Vijai, Z. Stadler, S. Lipkin, K. Offit,
M. Robson, First and second authors have equal
contributions.
2471
W How interested are parents in genome
screening for their newborns?
R. C. Green, S. S. Kalia,
H. L. Levy, I. A. Holm, S. E. Waisbren.
2472
T Psychological responses to genetic risk
disclosure among individuals at imminent risk for
Alzheimer’s disease and their study partners: Findings
from the REVEAL study.
K. D. Christensen, J. S. Roberts,
J. H. Karlawish, T. O. Obisesan, L. B. Waterston, L. A.
Cupples, W. R. Uhlmann, E. McCarty Wood, R. C. Green,
on behalf of REVEAL Study Group.
2473
W The impact of genetic risk disclosure for
Alzheimer’s disease: Findings from the REVEAL Study
APOE
e
4
homozygotes.
L. B. Waterston, J. H. Karlawish,
J. S. Roberts, C. A. Chen, K. D. Christensen, R. C. Green,
for REVEAL Study Group.
2450
T Frequency of ACMG recommended 57 gene
incidental findings f om whole exome sequencing in a
cohort of 47 adult individuals.
J. Wynn, M. L. Cremona,
J. Martinez, Y. H. Cheung, W. K. Chung.
2451
W Incidental findings and the ACMG guidelines:
What is the real burden?
J. J. Johnston, D. Ng, S. G.
Gonsalves, K. L. Lewis, D. N. Cooper, J. Berg, H. L. Rehm,
L. G. Biesecker.
2452
T An assessment of the prevalence of rare
nonsynonymous variants within the genes listed in the
ACMG Recommendations for Reporting of Incidental
Findings in Clinical Exome and Genome Sequencing.
S. P. Strom, H. Lee, J. L. Deignan, K. Das, E. Vilain, W. W.
Grody, S. F. Nelson.
2453
W Do preferences matter? Creating and assessing
a novel preference-setting tool for the return of
genomic research results.
P. L. Bacon, S. K. Savage, S. I.
Ziniel, K. D. Christensen, N. L. Huntington, E. R. Weitzman,
P. L. Taylor, R. C. Green, I. A. Holm.
2454
T Biobank participants’ perspectives on aggregate
result return.
E. Bane, E. Ludman, J. Richards, G. Jarvik,
S. M. Fullerton.
2455
W Scripps Idiopathic Diseases of Man Study:
The first 2 years
C. S. Bloss, S. Topol, B. F. Darst,
A. Torkamani, N. J. Schork, E. J. Topol.
2456
T Should secondary findings f om whole
exome and whole genome sequencing be released
to research subjects? Our ethical responsibility.
C. A. Campbell, T. Bair, D. Kolbe, R. J. H. Smith.
2457
W “We don’t know her history, her background”:
Adoptive parents’ perspectives about sequencing
results.
J. Crouch, J. Yu, A. G. Shankar, H. K. Tabor.
2458
T Human genetic researchers and biobank
leaders support the return of high-risk, actionable
research findings but face numerous impediments
to responsible return of results.
R. Dvoskin, J.
Bollinger, K. Kreger, A. A. Padon, K. L. Edwards, D.
Kaufman.
2459
W Focus group exploration of return of research
results.
W. A. Faucett, S. N. Fetterolf, L. H. Rogers, S. A.
Martin, M. S. Williams, D. J. Carey.
2460
T Pleiotropy and the potential return of (additional)
incidental information with incidental result return.
S.
M. Fullerton, J. M. Kocarnik.
2461
W Reasons associated with different levels of
interest in receiving individual genetic research results:
A public survey.
L. Jamal, J. Bollinger, R. Dvoskin, D.
Kaufman.
2462
T User satisfaction with a web-based tool
for self-guided management of results from ES/
WGS.
S. M. Jamal, J. Yu, J. Crouch, A. A. Lemke, M.
J. McMillin, A. G. Shankar, K. M. Dent, M. J. Bamshad,
H. K. Tabor.